Evidence map›Paper›PMID 29167179›Full record

ReviewThe Journal of cell biology2017

Proteinopathies and OXPHOS dysfunction in neurodegenerative diseases.

Hibiki Kawamata, Giovanni Manfredi

Erratum issuedOpen access · bronzeAbstract readReview
In one paragraph

Review in The Journal of cell biology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 51 papers.

0numbers the graph read from it
0cells of the map it votes in
51citing papers in PubMed
4.6field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

51 citing papers in PubMed, 86 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Functional Relationships between L1CAM, LC3, ATG12, and Aβ.International journal of molecular sciences · 2024
    Article
  11. Article
  12. Review
  13. Article
  14. Mitochondrial heterogeneity in diseases.Signal transduction and targeted therapy · 2023
    Review
  15. A glance through the effects of CD4Computational and structural biotechnology journal · 2023
    Review
  16. Review
  17. Mitochondrial and Neuronal Dysfunctions in L1 Mutant Mice.International journal of molecular sciences · 2022
    Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Hibiki KawamataFeil Family Brain and Mind Research Institute, Weill Cornell Medicine, New York, NY.
Giovanni ManfrediFeil Family Brain and Mind Research Institute, Weill Cornell Medicine, New York, NY gim2004@med.cornell.edu.ORCID 0000-0003-3893-1348
Cornell University · US

Funding

Mitochondria quality control in SOD1-ALSR01NS062055 · NINDS · WEILL MEDICAL COLL OF CORNELL UNIV · PI MANFREDI, GIOVANNI · 2009 to 2019
$3.7M
Metabolic profiling of sporadic ALS patients: from fibroblasts to neurons and backR01NS093872 · NINDS · WEILL MEDICAL COLL OF CORNELL UNIV · PI GROSS, STEVEN S, MANFREDI, GIOVANNI · 2015 to 2019
$2.7M
NINDS NIH HHS R01 NS062055NINDS NIH HHS R01 NS093872
6 · The paper itself

Abstract

Mitochondria participate in essential processes in the nervous system such as energy and intermediate metabolism, calcium homeostasis, and apoptosis. Major neurodegenerative diseases are characterized pathologically by accumulation of misfolded proteins as a result of gene mutations or abnormal protein homeostasis. Misfolded proteins associate with mitochondria, forming oligomeric and fibrillary aggregates. As mitochondrial dysfunction, particularly of the oxidative phosphorylation system (OXPHOS), occurs in neurodegeneration, it is postulated that such defects are caused by the accumulation of misfolded proteins. However, this hypothesis and the pathological role of proteinopathies in mitochondria remain elusive. In this study, we critically review the proposed mechanisms whereby exemplary misfolded proteins associate with mitochondria and their consequences on OXPHOS.

Indexed as

Oxidative Phosphorylationalpha-SynucleinAmyloid beta-PeptidesAnimalsGene Expression RegulationHumansMitochondriaMitochondrial ProteinsNeurodegenerative DiseasesProtein Interaction MappingProteostasis Deficienciesalpha-SynucleinAmyloid beta-PeptidesMitochondrial Proteins

Identifiers

PMID29167179
PMCPMC5716291
OpenAlexW2769977812

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.